Emilia Arturo: Give Your Hematology Paper a Second Chance
Emilia (Emily) Arturo, Senior Managing Editor of Blood and Blood Global Hematology, shared a post by Blood Journals Portfolio on LinkedIn:
”Have a paper already reviewed and rejected at another reputable hematology, immunology, oroncology journal? Consider submitting the paper and its reviews for a Second Look Rapid Response from one of these Blood Journals.”
Quoting Blood Journals Portfolio’s post:
”Submitting to a top medical journal can be a long process and not getting published can feel like a setback. However, it doesn’t have to be the end of your manuscript’s journey.
The five specialized journals in the Blood Journals portfolio, Blood ICT, Blood RCI, Blood VTH, Blood Neoplasia, and Blood Global Hematology are offering authors a rapid second look. If you have research within the scope of one of these journals, you could get published soon with the backing of the renowned Blood brand. It’s simple:
- Update and submit a manuscript previously submitted to another reputable journal (with reviewer feedback)
- Receive an initial editorial assessment within just 3 business days
- Just 8 weeks from submission to publishing of first edition
Your work deserves to be seen. Learn more here.”
Stay updated with Hemostasis Today.
-
Jan 29, 2026, 14:02Emma Lefrancais on Alarmin IL33 and Platelet Biology
-
Jan 29, 2026, 13:44Sia A: One of My Favorite Conversations from ASH
-
Jan 29, 2026, 13:34Sarah Matuja on Tanzania Stroke Project
-
Jan 29, 2026, 13:28Nancy Di Salvo on Amplifying Rare Disease Voices Through Partnership
-
Jan 29, 2026, 13:21Raul Santos Shares The Results of ORION-16: On The Efficacy and Safety of Inclisiran
-
Jan 29, 2026, 05:22Aravind Palraj Draws a Comparison Between APS and Lupus Cerebritis
-
Jan 29, 2026, 05:09Edina Cenko on Expanding Cardiovascular Risk: From Ischaemia to Emerging Frontiers
-
Jan 29, 2026, 04:58Anna Randi Shares the Latest Episode of The VWF and Angiogenesis Story from Her Lab
-
Jan 29, 2026, 04:49Ruah Alyamany on Her Contribution to Establishing The Role of IgM in APS